1-5 of 5
Kaori Okada
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3907: Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types

Darwin Kwok, Nicholas O. Stevers, Takahide Nejo, Lee H. Chen, Inaki Etxeberria, Jangham Jung, Kaori Okada, Maggie Colton Cove, Senthilnath Lakshmanachetty, Marco Gallus, Abhilash Barpanda, Chibo Hong, Gary KL Chan, Samuel H. Wu, Emilio Ramos, Akane Yamamichi, Jerry YZ Liu, Payal Watchmaker, Hirokazu Ogino, Atsuro Saijo, Aidan Du, Nadia Grishanina, James Woo, Aaron Diaz, Susan M. Chang, Joanna J. Phillips, Arun P. Wiita, Christopher A. Klebanoff, Joseph F. Costello, Hideho Okada
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3907.
https://doi.org/10.1158/1538-7445.AM2024-3907
Published: 22 March 2024
View article titled, Abstract 3907: Novel public and tumor-wide neoantigens arising from clonal aberrant splicing events drive tumor-specific T-cell responses across diverse cancer types
Journal Articles

Abstract 3152: Targetable public neoantigens are generated by tumor-wide cancer-specific splicing events in gliomas

Darwin W. Kwok, Takahide Nejo, Nicholas Stevers, Lee H. Chen, Kaori Okada, Chibo Hong, Gary K. Chan, Akane Yamamichi, Aidan Du, Maggie Colton, James Woo, Joseph Costello, Hideho Okada
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3152.
https://doi.org/10.1158/1538-7445.AM2023-3152
Published: 04 April 2023
View article titled, Abstract 3152: Targetable public neoantigens are generated by tumor-wide cancer-specific splicing events in gliomas
Journal Articles

Abstract 3767: Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma

Zinal Chheda, Gary Kohanbash, John Sidney, Kaori Okada, Naznin Jahan, Diego Carrera, Payal Watchmaker, Kira Downey, Shuming Liu, Shruti Shrivastav, Sabine Mueller, Ian F. Pollack, Angel M. Carcaboso, Alessandro Sette, Yafei Hou, Hideho Okada
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3767.
https://doi.org/10.1158/1538-7445.AM2017-3767
Published: 01 July 2017
View article titled, Abstract 3767: Identification of a novel and a shared H3.3K27M mutation derived neoantigen epitope and H3.3K27M specific TCR engineered T cell therapy for glioma
Journal Articles

Delivery of Interferon-α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines

Hideho Okada, Takahiko Tsugawa, Hidemitsu Sato, Naruo Kuwashima, Andrea Gambotto, Kaori Okada, Jill E. Dusak, Wendy K. Fellows-Mayle, Glenn D. Papworth, Simon C. Watkins, William H. Chambers, Douglas M. Potter, Walter J. Storkus, Ian F. Pollack
Journal: Cancer Research
Cancer Res (2004) 64 (16): 5830–5838.
https://doi.org/10.1158/0008-5472.CAN-04-0130
Published: 16 August 2004
View article titled, Delivery of Interferon-α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines
Open the PDF for Delivery of Interferon-α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines in another window
Journal Articles

Potent therapeutic efficacy against intracranial tumors by cytokine-gene transfected peripheral tumor cell-vaccines in combination with intracranial injection of IFN-α transfected DCs: Induction of trail on tumor specific cytotoxic T cells.

Naruo Kuwashima, Naruo Kuwashima, Jill E. Dusak, Wendy F. Fellows, Andrea Gambotto, Manabu Hatano, Hideho Okada, Kaori Okada, Ian F. Pollack, Tsukasa Sakaida, Hidemitsu Sato, Takahiko Tsugawa
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 496.
Published: 01 April 2004
View article titled, Potent therapeutic efficacy against intracranial tumors by cytokine-gene transfected peripheral tumor cell-vaccines in combination with intracranial injection of IFN-α transfected DCs: Induction of trail on tumor specific cytotoxic T cells.